Karyopharm Therapeutics KPTI Balance Sheet (2012-2026)

NASDAQ KPTI
$1.63 -0.06 (-3.25%)
As of: Sep 10, 2026 · 11:10 AM EDT
Reported Financials

Karyopharm Therapeutics Quarterly Balance Sheet

Periods 54 quarters
Latest Jun 2026

Karyopharm Therapeutics reported total assets of $111.32M and total liabilities of $441.49M for the quarter ended Jun 2026, down 12.8% year over year. This balance sheet covers 54 quarters of results from Dec 2012 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
141.31M137.40M190.46M153.26M82.25M71.35M135.19M84.06M80.89M43.66M52.23M30.63M84.77M72.83M98.30M54.28M38.73M37.67M60.54M54.98M
Short-term InvestmentsInvestments (Current)
94.58M66.81M38.16M52.05M88.60M77.03M142.78M176.32M155.87M164.66M139.21M117.95M67.35M60.70M46.24M31.16M12.97M8.21M3.20M10.12M
Cash & Current Investments
235.89M204.21M228.62M205.31M170.85M148.38M277.97M260.38M236.76M208.31M191.44M148.58M152.12M133.53M144.53M85.43M51.70M45.88M63.74M65.11M
Receivables - NetNet Receivables
17.89M18.75M22.50M24.99M23.48M27.45M47.09M35.20M32.28M37.92M26.96M31.08M37.99M31.78M30.77M35.24M32.93M31.88M26.18M29.87M
Receivables - OtherOther Receivables
Receivables
17.89M18.75M22.50M24.99M23.48M27.45M47.09M35.20M32.28M37.92M26.96M31.08M37.99M31.78M30.77M35.24M32.93M31.88M26.18M29.87M
Raw Materials
1.82M1.71M1.80M2.56M0.26M0.26M1.37M1.12M1.12M0.39M0.55M0.55M0.72M0.72M0.72M0.51M0.48M0.63M0.63M0.63M
Work In Process
1.86M1.83M1.90M0.93M2.87M3.00M1.88M1.77M1.70M1.96M1.73M1.59M2.15M3.41M3.54M3.91M4.17M2.90M2.98M3.17M
Finished Goods
0.22M0.40M0.41M0.39M0.34M0.99M0.98M0.94M0.85M0.76M0.76M0.63M0.60M0.54M0.48M0.35M0.35M0.43M0.43M0.20M
Inventory
3.90M3.94M4.11M3.87M3.47M4.25M4.22M3.83M3.67M3.10M3.04M2.77M3.48M4.67M4.74M4.77M4.99M3.97M4.04M3.99M
Prepaid Assets
15.06M12.27M14.04M29.14M32.08M31.47M19.82M18.28M18.10M13.33M11.81M15.48M14.91M14.75M12.24M10.29M8.25M8.03M9.19M7.41M
Current Assets
273.50M241.58M275.61M276.53M242.45M222.68M350.16M318.54M291.38M263.22M233.92M198.37M208.54M184.75M156.46M120.24M97.87M89.75M103.15M106.38M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net)
1.75M1.57M1.64M1.54M1.40M1.25M1.14M0.85M0.77M0.69M0.61M0.72M0.63M0.49M0.40M0.32M0.24M0.12M0.10M0.09M
Long-Term Investments
2.01M2.00M
Long-Term Deferred Tax
Other Non-Current Assets
0.64M0.64M0.64M0.64M0.63M0.63M0.63M0.63M0.39M0.38M0.30M0.30M0.30M0.31M1.33M1.33M0.35M1.33M0.35M0.32M
Non-Current Assets
13.06M12.52M29.70M17.50M14.03M8.56M8.01M7.26M6.45M6.74M6.52M6.09M5.44M4.72M7.96M7.47M7.01M6.49M5.27M4.94M
Assets
286.57M254.09M305.31M294.03M256.48M231.24M358.17M325.80M297.83M269.96M240.44M204.46M213.98M189.48M164.42M127.71M104.88M96.23M108.42M111.32M
Liabilities
Current Liabilities
Accounts Payables
2.31M0.88M1.60M3.44M1.69M0.81M2.77M9.04M2.29M0.94M3.12M5.03M2.80M5.78M5.11M5.87M2.60M5.39M4.00M7.66M
Payables
2.31M0.88M1.60M3.44M1.69M0.81M2.77M9.04M2.29M0.94M3.12M5.03M2.80M5.78M5.11M5.87M2.60M5.39M4.00M7.66M
Accumulated Expenses
53.21M64.70M69.12M58.37M56.37M55.72M58.41M47.03M51.81M55.71M61.39M54.85M49.81M50.10M60.65M57.17M62.93M66.33M64.50M78.80M
Other Accumulated Expenses
0.52M1.12M7.62M2.06M1.86M2.46M6.41M2.50M1.75M2.23M7.12M2.04M1.47M1.94M4.77M1.94M1.57M1.76M1.58M6.39M
Short term Debt
6.25M12.50M21.01M40.31M
Current Leases
2.08M2.16M2.32M2.46M2.62M2.77M2.87M2.98M3.08M3.19M3.31M3.42M3.54M3.67M0.44M0.93M1.38M0.92M0.97M1.07M
Current Deferred Revenue
Total Current Liabilities
58.12M68.87M73.72M66.34M62.54M61.76M65.91M61.55M58.93M62.08M69.48M65.34M57.62M61.49M92.26M90.37M99.22M87.16M92.06M134.23M
Non-Current Liabilities
Non-Current Debt
93.52M94.11M94.60M95.20M89.57M83.89M94.80M85.05M
Convertible Debt
168.90M169.09M169.29M169.49M169.69M169.89M170.10M170.31M170.50M170.70M170.92M171.13M
Non-Current Deffered Revenue
Preferred Stock Liabilities
Non-Current Deferred Tax LiabilityNon-Current Deferred Tax
Operating Leases
10.20M9.63M8.97M8.29M7.58M6.86M6.10M5.31M4.50M3.67M2.79M1.88M0.95M6.71M6.49M6.25M6.01M5.74M5.18M
Other Non-Current Liabilities
132.48M132.48M133.00M133.00M133.00M133.00M132.72M132.72M132.72M132.48M132.48M132.48M73.50M73.50M73.50M73.50M73.50M73.50M72.34M72.34M
Total Non-Current Liabilities
237.22M247.59M251.98M244.11M239.82M238.52M242.11M238.26M236.36M237.88M244.16M240.93M272.62M275.62M276.94M260.10M270.31M291.99M329.00M369.15M
Total Liabilities
369.70M380.07M384.98M377.11M372.82M371.52M374.83M370.97M369.08M370.36M376.64M373.41M346.12M349.12M350.44M333.60M343.81M365.49M401.34M441.49M
Shareholder's Equity
Total Debt
93.52M94.11M94.60M95.20M95.82M96.39M115.81M125.35M
Common Equity
-83.13M-125.98M-79.67M-83.08M-116.34M-140.28M-16.66M-45.17M-71.25M-100.40M-136.21M-168.96M-132.14M-159.65M-186.02M-205.88M-238.93M-269.26M-292.93M-330.17M
Liabilities and Shareholders Equity
286.57M254.09M305.31M294.03M256.48M231.24M358.17M325.80M297.83M269.96M240.44M204.46M213.98M189.48M164.42M127.71M104.88M96.23M108.42M111.32M
Retained Earnings
-1165.56M-1217.37M-1178.65M-1220.05M-1269.11M-1305.43M-1343.94M-1378.07M-1410.69M-1445.20M-1487.04M-1524.40M-1500.61M-1532.68M-1563.46M-1600.00M-1624.17M-1700.00M-1759.50M-1848.91M
Treasury Shares